Background

Laboratorio DOSA S.A., a company with Argentinean and Uruguayan capitals, started its activities in February of 1999 for the research, development, marketing and promotion of oncological, neuroleptic and AIDS specialities.

Mission

The present commercial line is focused on oncology, AIDS and psychiatry. Nowadays, supplementary products, such as immunossuppressant, high complex biotechnological and over-the-counter pharmaceutical products, are under development.

Laboratorio DOSA S.A. has a Quality Control laboratory eqquipped with state-of-the-art technology. Each area has been conceived with a modern concept fulfilling ANMAT requeriments and regulations from: GMP - MERCOSUR - *****. - *****. - F.D.A.

Premises and Professional

Professionals are highly qualified, receive continuous updating and have wide experience after been in the pharmacology industry for more than 10 years.

Positions

Further to supplying the local market, Laboratorio Dosa S.A. exports to Latin America, Europe and Middle East countries competing with prices and quality.

docetaxel, taxotere, anti-mitotic chemotherapy, breast treatment, white powder, docetaxel drugs, pharmaceutical drug, docetaxel supplier, docetaxel exporter, filgrastim, granulocytes, neupogen, 143011-72-7, c845h1343n223o243s9, neutropenia, filgrastim supplier, filgrastim exporter, melfalan, melphalan hydrochloride, alkeran, chemotherapy drug, 148-82-3, c13h18cl2n2o2, malignant melanoma, melfalan supplier, melfalan exporter, paclitaxel, mitotic inhibitor, cancer chemotherapy, taxol, 33069-62-4, c47h51no14, paclitaxel supplier, paclitaxel exporter, oxaliplatin, 63121-00-6, c8h14n2o4pt, oxaliplatin chemotherapy, oxaliplatin drug, chemotherapy drugs, breast cancer chemotherapy treatment, chemotherapy treatment, decitabine, dacogen, drug, dacogen chemotherapy drugs, decitabine injection, demethylating agent, decitabine drug supplier, decitabine drug exporter, c8h12n4o4, 2353-33-5, fluradabine, fludarabine phosphate,